AOD-9604 Metabolic Control refers to the therapeutic application of the AOD-9604 peptide fragment to precisely regulate lipid metabolism and promote targeted lipolysis, specifically within adipose tissue. This clinical strategy is employed to manage body composition by influencing the breakdown of fat without stimulating the proliferation of fat cells. It represents a focused, non-growth hormone-dependent approach to metabolic optimization in the wellness space.
Origin
AOD-9604 is a synthetic fragment of the human Growth Hormone (hGH) molecule, specifically comprising the C-terminus region responsible for the fat-reducing effects of hGH. Research initially focused on developing an anti-obesity drug that avoided the undesirable side effects of full hGH, such as insulin resistance. This fragment was isolated and studied for its potent, localized metabolic action on fat cells.
Mechanism
The peptide fragment AOD-9604 functions by mimicking the action of hGH on fat metabolism but acts directly on the beta-3 adrenergic receptors in adipocytes. It stimulates lipolysis, the breakdown of stored triglycerides into free fatty acids, without activating the primary Growth Hormone receptor itself. Crucially, this mechanism avoids the insulinotropic effects associated with full-length Growth Hormone, thereby supporting glucose homeostasis while selectively targeting fat reduction for improved body composition.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.